Pavešić Radonja, A., Blažević Zelić, S., Rubeša, G. & Bradshaw, N. J. (2023). Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study. Psychiatria Danubina, 35. (2), 180-186. doi: 10.24869/psyd.2023.180
Pavešić Radonja, Aristea, et al. "Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study." Psychiatria Danubina, vol. 35, no. 2, 2023, pp. 180-186. https://doi.org/10.24869/psyd.2023.180
Pavešić Radonja, Aristea, Sandra Blažević Zelić, Gordana Rubeša and Nicholas J. Bradshaw. "Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study." Psychiatria Danubina 35, no. 2 (2023): 180-186. https://doi.org/10.24869/psyd.2023.180
Pavešić Radonja, A., et al. (2023) 'Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study', Psychiatria Danubina, 35(2), pp. 180-186. doi: 10.24869/psyd.2023.180
Pavešić Radonja A, Blažević Zelić S, Rubeša G, Bradshaw NJ. Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study. Psychiatria Danubina [Internet]. 2023 [cited 2024 December 24];35(2):180-186. doi: 10.24869/psyd.2023.180
A. Pavešić Radonja, S. Blažević Zelić, G. Rubeša and N. J. Bradshaw, "Symptom severity in schizophrenia patients with NPAS3, dysbindin-1 and/or TRIOBP protein pathology in their blood serum: a PANSS-based follow up study", Psychiatria Danubina, vol. 35, no. 2, pp. 180-186, 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:193:426049. [Accessed: 24 December 2024]